Modexa

Modexa

mometasone

Manufacturer:

Dexa Medica
Concise Prescribing Info
Contents
Mometasone furoate
Indications/Uses
Symptomatic relief of seasonal or perennial rhinitis especially in moderate to severe persistent allergy in adults, adolescents & childn 2-11 yr. Nasal polyps in adults ≥18 yr. Symptoms associated w/ mild to moderate uncomplicated acute rhinosinusitis in adults & childn ≥12 yr where signs or symptoms of bacterial infection are not present.
Dosage/Direction for Use
Seasonal allergic or perennial rhinitis Adult, childn ≥12 yr & elderly 2 sprays in each nostril once daily. Maintenance: 1 spray in each nostril once symptoms are controlled. May be increased to a max dose of 4 sprays in each nostril once daily if symptoms are not adequately controlled. Childn 2-11 yr 1 spray in each nostril once daily. Nasal polyposis Adult, adolescent ≥18 yr & elderly 2 sprays in each nostril twice daily. Reduce dose to 2 sprays in each nostril once daily when symptoms are adequately controlled. Mild to moderate uncomplicated acute rhinosinusitis 2 sprays in each nostril twice daily.
Contraindications
Hypersensitivity. Presence of untreated localized infection involving the nasal mucosa. Recent nasal surgery or trauma.
Special Precautions
Periodically examine patients in long-term treatment (several mth or longer) for possible changes in the nasal mucosa. Discontinue therapy if localized fungal infection of the nose or pharynx develops or nasopharyngeal irritation is persistent. Patients w/ active or quiescent tuberculous infections of the resp tract, untreated fungal, bacterial, systemic viral infections or ocular herpes simplex; transferred from long-term administration of systemically active corticosteroids. Joint & or muscular pain, lassitude, depression may be experienced by patients transferring from systemic corticosteroids. Risk of exposure to certain infections (eg, chickenpox, measles) in the immunosuppressed. Nasal septum perforation or increased IOP; growth retardation in childn. Regularly monitor height of childn receiving prolonged therapy. Adrenal suppression w/ higher than recommended doses. Consult physician if signs or symptoms of severe bacterial infection are observed. Unilateral polyps, polyps associated w/ cystic fibrosis, polyps that completely obstruct the nasal cavities. Pregnancy & lactation. Rhinosinusitis in childn <12 yr. Nasal polyposis in childn & adolescents <18 yr.
Adverse Reactions
Headache, epistaxis, pharyngitis, nasal burning, irritation & ulceration.
Drug Interactions
Increased plasma conc w/ CYP3A4 inhibitors eg, ketoconazole.
ATC Classification
R01AD09 - mometasone ; Belongs to the class of topical corticosteroids used for prophylaxis and treatment of allergic rhinitis.
Presentation/Packing
Form
Modexa nasal spray 50 mcg
Packing/Price
60 spray x 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in